small-logo
ProfessionalsCapabilitiesInsights & NewsCareersLocations
About UsAlumniOpportunity & InclusionPro BonoCorporate Social Responsibility
Stay Connected:
facebookinstagramlinkedintwitteryoutube
Site Search
  • Professionals (453)
  • Capabilities (83)
  • Experience (176)
  • Insights & News (2,214)
  • Other Results (48)

Professionals 453 results

Basil Godellas
Basil Godellas
Partner
  • Chicago
Email
+1 312-558-7237
vCard

Partner

  • Chicago
Samantha Lerner
Samantha Lerner
Partner
  • Chicago
Email
+1 312-558-6463
vCard

Partner

  • Chicago
Thomas B. Walsh
Thomas B. Walsh
Partner
  • Dallas
Email
+1 214-453-6460
vCard

Partner

  • Dallas
View All Professionals

Capabilities 83 results

Practice Area

Class Actions & Group Litigation

Winston has developed a consistent record of success handling class action cases in state and federal courts. The practice is anchored by seasoned class action lawyers, many of whom have been recognized by Chambers USA and other ranking organizations as being top practitioners in their field. Our clients rely on us to steer them through class action matters by drawing on the firm’s significant experience in resolving complex litigation using creative and aggressive arguments, across a broad range of class, collective, coordinated, and mass actions, as well multidistrict litigation. We also have succeeded at trial in several class actions—a rare occurrence....Read more

Practice Area

Real Estate

Today’s dynamic commercial real estate market calls for attorneys who bring a broad platform of skills and experience to the table. Our real estate practice offers institutional knowledge across an extensive array of real estate transactions....Read more

Practice Area

Bankruptcy Litigation & Investigations

Large corporate bankruptcies and companies in financial distress often spawn a complex web of claims by lenders, trustees, debtors, creditors, creditors’ committees, investors, shareholders, and other constituents. Attorneys in Winston & Strawn’s complex commercial litigation group and special situations and restructuring group serve as trusted advisors and resolute advocates to protect clients’ business interests and assets in multifaceted Chapter 11 cases and bankruptcy-related disputes. ...Read more

Experience 176 results

Experience

|

January 19, 2026

Winston Advises smartTrade Technologies Group on the Acquisition of kACE

A cross-border team from advised smartTrade Technologies Group (“smartTrade”), a leading provider of multi-asset electronic trading and payments solutions, on its acquisition of kACE Financial (“kACE”), formerly known as Fenics, a well-established provider of technology solutions for FX and interest rate derivatives pricing, analytics, and workflow management....Read more

Experience

|

January 6, 2026

Brightwood Capital’s Acquisition of Museum of Illusions Group

A team led by Bradley Vaiana and Austin Leach represented Brightwood Capital Advisors, LLC (“Brightwood”), a New York–based investment firm, in its acquisition of Museum of Illusions Group, the world’s largest privately held chain of museums, from Invera Capital Partners. As part of the transaction, five previously franchised locations will transition from the chain’s largest franchisee, LOL Entertainment, to become corporate-owned sites. Winston attorneys across multiple practice areas and offices, including M&A, Tax, Intellectual Property, Employee Benefits, and the firm’s UK office, assisted in structuring a complex cross-border transaction to support Brightwood's fund investment goals. The acquisitions were completed on January 6, 2026....Read more

Experience

|

December 16, 2025

Winston & Strawn advises on financing of World Fencing League

Winston & Strawn LLP has advised World Fencing League (WFL) on its successful financing from the Flick Family Office, supporting WFL’s mission to transform fencing from a niche Olympic discipline into a modern, fan-driven global sport....Read more
View All Experience

Insights & News 2,214 results

Recognitions

|

January 30, 2026

|

1 Min Read

Winston Trademark Team Recognized in the WTR 1000 2026 Rankings

Winston & Strawn is once again recognized in World Trademark Review (WTR) 1000. WTR undertakes exhaustive qualitative research to identify the leading professionals and firms that are deemed outstanding at obtaining, protecting, managing, enforcing, and monetizing trademarks....Read more

Benefits Blast

|

January 30, 2026

|

2 Min Read

New Executive Order Targets Proxy Advisory Firms: Key ERISA Implications

On December 11, 2025, President Trump issued an executive order (the Order) targeting the two major proxy advisory firms, ISS and Glass Lewis. The Order asserts that these firms often prioritize political agendas, particularly diversity, equity, and inclusion (DEI) and environmental, social, and governance (ESG) initiatives,  over investor returns.  As a result, the Order directed the US Department of Labor (DOL) and other agencies to take certain actions. The resulting DOL action could have significant impact for ERISA plan fiduciaries.

Seminar/CLE

|

January 29, 2026

Winston Hosts 2026 Financial Services Symposium in Charlotte

 

 

View All Insights & News

Other Results 48 results

Law Glossary

What Is a Class Action?

A class action is a procedural device that allows one or more persons, usually plaintiffs (though federal and state procedural rules also authorize defendant classes) to file suit on behalf of a group of similarly situated persons. Federal law defines a class action as “any civil action filed under Rule 23 of the Federal Rules of Civil Procedure or similar State statute or rule of judicial procedure authorizing an action to be brought by 1 or more representative persons as a class action.”  28 U.S.C. § 1332(d)(1)(B), (d)(8)....Read more

Law Glossary

What Statutes and Regulations Govern the Approval and Marketing of Biosimilars?

Congress passed the Biologics Price Competition and Innovation Act of 2009 (BPCIA) in 2010 an amendment of the Public Health Services Act. The BPCIA is codified at 42 U.S.C. § 262....Read more

Law Glossary

What Exclusivity Periods Are Associated with Biosimilars?

An applicant may not submit an aBLA until four years after the reference product is licensed by the FDA. (See BPCIA § 351(k).) Further, any biosimilar licenses “may not be made effective” until 12 years after the reference product was licensed. (See BPCIA § 351(l).)...Read more
Logo
facebookinstagramlinkedintwitteryoutube

Copyright © 2026. Winston & Strawn LLP

AlumniCorporate Transparency Act Task ForceDEI Compliance Task ForceEqual Rights AmendmentLaw GlossaryThe Oval UpdateWinston MinutePrivacy PolicyCookie PolicyFraud & Scam AlertsNoticesSubscribeAttorney Advertising